In the current study, we reported the ability of mAB TPγ B9-2 to record changes in expression of PTPRG on neutrophils by flow cytometry technique and consequently classify the CML patients in the same manner. Here, PTPRG is linked to chronic myelogenous leukemia, BCR-ABL1 positive.